AFT Pharmaceuticals Limited (AFT.NZ)

NZD 2.63

(-1.9%)

Total Debt Summary of AFT Pharmaceuticals Limited

AFT Pharmaceuticals Limited's latest annual total debt in 2024 was 32.18 Million NZD , down -15.4% from previous year.
AFT Pharmaceuticals Limited's latest quarterly total debt in 2024 FY was 32.18 Million NZD , down -15.4% from previous quarter.
AFT Pharmaceuticals Limited reported annual total debt of 38.04 Million NZD in 2023, down -6.07% from previous year.
AFT Pharmaceuticals Limited reported annual total debt of 40.5 Million NZD in 2022, down -4.05% from previous year.
AFT Pharmaceuticals Limited reported quarterly total debt of 31.39 Million NZD for 2024 Q3, down -23.34% from previous quarter.
AFT Pharmaceuticals Limited reported quarterly total debt of 40.2 Million NZD for 2024 Q1, up 5.67% from previous quarter.

Annual Total Debt Chart of AFT Pharmaceuticals Limited (2024 - 2013)

Historical Annual Total Debt of AFT Pharmaceuticals Limited (2024 - 2013)

Year	Total Debt	Total Debt Growth
2024	32.18 Million NZD	-15.4%
2023	38.04 Million NZD	-6.07%
2022	40.5 Million NZD	-4.05%
2021	42.21 Million NZD	-10.56%
2020	47.2 Million NZD	13.06%
2019	41.75 Million NZD	36.2%
2018	30.65 Million NZD	30.85%
2017	23.42 Million NZD	12.27%
2016	20.86 Million NZD	0.61%
2015	20.73 Million NZD	57.87%
2014	13.13 Million NZD	4.74%
2013	12.54 Million NZD	0.0%

Year	Total Debt	Total Debt Growth
2024 FY	32.18 Million NZD	-15.4%
2024 Q3	31.39 Million NZD	-23.34%
2024 Q1	40.2 Million NZD	5.67%
2024 Q4	32.18 Million NZD	2.54%
2024 Q2	40.95 Million NZD	1.86%
2023 Q3	37.47 Million NZD	-9.27%
2023 Q4	38.04 Million NZD	1.52%
2023 FY	38.04 Million NZD	-6.07%
2023 Q1	40.79 Million NZD	0.7%
2023 Q2	41.3 Million NZD	1.26%
2022 Q1	41.48 Million NZD	-1.72%
2022 Q4	40.5 Million NZD	1.36%
2022 Q3	39.96 Million NZD	-4.99%
2022 FY	40.5 Million NZD	-4.05%
2022 Q2	42.06 Million NZD	1.39%
2021 Q2	44.19 Million NZD	1.36%
2021 Q1	43.59 Million NZD	-7.64%
2021 Q3	41.6 Million NZD	-5.86%
2021 Q4	42.21 Million NZD	1.48%
2021 FY	42.21 Million NZD	-10.56%
2020 Q4	47.2 Million NZD	1.08%
2020 Q2	49.97 Million NZD	1.08%
2020 Q1	49.44 Million NZD	18.42%
2020 FY	47.2 Million NZD	13.06%
2020 Q3	46.69 Million NZD	-6.56%
2019 Q4	41.75 Million NZD	0.0%
2019 FY	41.75 Million NZD	36.2%
2019 Q3	41.75 Million NZD	-0.45%
2019 Q2	41.93 Million NZD	0.0%
2019 Q1	41.93 Million NZD	36.81%
2018 Q1	23.24 Million NZD	-0.78%
2018 Q4	30.65 Million NZD	0.0%
2018 Q3	30.65 Million NZD	31.88%
2018 Q2	23.24 Million NZD	0.0%
2018 FY	30.65 Million NZD	30.85%
2017 FY	23.42 Million NZD	12.27%
2017 Q2	22.03 Million NZD	0.0%
2017 Q1	22.03 Million NZD	-4.84%
2017 Q3	23.42 Million NZD	6.29%
2017 Q4	23.42 Million NZD	0.0%
2016 Q3	23.16 Million NZD	0.0%
2016 Q2	- NZD	-100.0%
2016 FY	20.86 Million NZD	0.61%
2016 Q4	23.16 Million NZD	0.0%
2016 Q1	24.72 Million NZD	19.2%
2015 Q4	20.73 Million NZD	0.0%
2015 Q1	- NZD	0.0%
2015 Q3	20.73 Million NZD	0.0%
2015 FY	20.73 Million NZD	57.87%
2014 FY	13.13 Million NZD	4.74%
2013 FY	12.54 Million NZD	0.0%

Peer Total Debt Comparison of AFT Pharmaceuticals Limited

Name	Total Debt	Total Debt Difference
Greenfern Industries Limited	854.24 Thousand NZD	-3668.235%
Rua Bioscience Limited	147.78 Thousand NZD	-21682.379%